AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 29 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,527,000 | +4.6% | 2,500,000 | -16.7% | 0.00% | 0.0% |
| Q3 2016 | $3,373,000 | -12.6% | 3,000,000 | -14.3% | 0.00% | 0.0% |
| Q2 2016 | $3,859,000 | -13.1% | 3,500,000 | -14.6% | 0.00% | -33.3% |
| Q1 2016 | $4,441,000 | -19.4% | 4,100,000 | -6.4% | 0.00% | 0.0% |
| Q4 2015 | $5,508,000 | -7.1% | 4,380,000 | +19.7% | 0.00% | -25.0% |
| Q3 2015 | $5,929,000 | -33.5% | 3,660,000 | +5.8% | 0.00% | -20.0% |
| Q2 2015 | $8,921,000 | -19.0% | 3,460,000 | -34.7% | 0.01% | -16.7% |
| Q1 2015 | $11,008,000 | +23.1% | 5,300,000 | 0.0% | 0.01% | +20.0% |
| Q4 2014 | $8,941,000 | – | 5,300,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 17,250,000 | $19,597,000 | 18.38% |
| STEELHEAD PARTNERS LLC | 17,000,000 | $19,264,000 | 1.88% |
| Bruce & Co., Inc. | 5,500,000 | $6,600,000 | 1.78% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 26,750,000 | $30,177,000 | 1.01% |
| Castle Creek Arbitrage, LLC | 3,721,000 | $4,215,000 | 0.43% |
| LINDEN ADVISORS LP | 7,000,000 | $7,909,000 | 0.36% |
| Sonora Investment Management, LLC | 1,510,000 | $1,702,676,000 | 0.36% |
| BASSO CAPITAL MANAGEMENT, L.P. | 2,110,000 | $2,382,000 | 0.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 18,400,000 | $20,808,000 | 0.31% |
| SSI INVESTMENT MANAGEMENT LLC | 1,975,000 | $2,221,000 | 0.20% |